NCT04510675: A trial that was reported late by Omeza, LLC
This trial has reported, although it was 120 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04510675 |
|---|---|
| Title | A 6-Week, Randomized, Evaluator-Blinded, In Vivo Within Subject Repeat Test to Evaluate the Irritation and Sensitization Potential of Omeza Collagen Matrix in Healthy Volunteers |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 2, 2019 |
| Completion date | Jan. 11, 2020 |
| Required reporting date | Jan. 10, 2021, midnight |
| Actual reporting date | May 11, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 120 |